Navigation Links
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life

UC's Overall Psychological Toll Is Greater Than for Asthma, Rheumatoid Arthritis and Migraines

WAYNE, Pa., May 17, 2007 /PRNewswire/ -- Nearly three out of four ulcerative colitis (UC) sufferers (73 percent) responding to a new nationwide survey say not feeling well has become a normal part of life. Furthermore, they describe UC as disruptive when it comes to their relationship with a spouse (64 percent), their sexual relations (75 percent) and their emotional state (82 percent).

UC patients "normalize" aspects of their experience to the point that they resign themselves to these burdens. The majority say that there is not much they can do beyond what they are already doing to feel better (70 percent) and they have learned to live with the disruptions that UC causes (83 percent).

"The findings sound an alarm because a diagnosis of UC shouldn't mean patients are settling for the level of burden reported in this survey for the next 50 or 60 years. UC is a manageable disease with the appropriate therapy," says David Rubin, M.D., a gastroenterologist and assistant professor of medicine at the University of Chicago Medical Center who helped design the surveys.

UC is a chronic autoimmune disease that causes inflammation in the intestine and can lead to symptoms such as severe abdominal pain and cramping, uncontrollable bloody diarrhea several times a day, fatigue and weight loss. It is typically first diagnosed in people between the ages of 15 to 30 and is estimated to affect nearly 700,000 Americans.

The objective of the surveys was to understand how UC affects patients' lives, including definitions of what's normal, the threshold for letting the disease disrupt life, and how patients manage their condition. The surveys, titled "UC: NORMAL (New Observations on Remission Management and Lifestyle)" were sponsored by Shire Pharmaceuticals, a specialty biopharmaceutical company which markets
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
2. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
3. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
4. Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW
5. Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
6. New Survey Finds Troubling Data on American Asthma Sufferers
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinsons Disease
11. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia
Post Your Comments:
(Date:7/24/2008)...Data Shows Increased Muscle and Blood Vessel Forma..., SUNRISE, Fla., July 24 /...ection of myoblasts modified to express,stromal de...r tissue of the,myocardium of rats, which suggest ...t two scientific meetings -- the International Soc...
(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Headlines claim...he whole story. The small scale,preliminary study...n,Reproduction, is based on recollected intake of ...oods. "This study is confounded by many,issues, th...t deal of,caution," warned Dr. Tammy Hedlund, a re...
(Date:7/24/2008)...ly 24 /- MacroChem Corporat...ults of a Phase 2 clinical trial,involving 37 pati...pen-label efficacy and safety study of EcoNail, a ...ychomycosis (nail fungus). The composite,primary e...defined as,negative mycology (negative fungal cult...
(Date:7/23/2008)...s pending publication in July print edition of Cli... Web, INDIANAPOLIS, July 23 /- A Roc...e use of N-terminal pro-B-type natriuretic peptide...oBNP for risk,stratification in predicting the ris...ents treated with non-steroidal anti-inflammatory ...
Breaking Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Soyfoods Do Not Impact Sperm Count 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4Wound Management Technologies Inc Announces Sales Agreement with EWA Government Systems Inc 22939 1Wound Management Technologies Inc Announces Sales Agreement with EWA Government Systems Inc 22939 2Wound Management Technologies Inc Announces Sales Agreement with EWA Government Systems Inc 22939 3Joseph B Bolen Ph D from Millennium to Conference Chair Cancer Sessions at IBCs Drug Discovery 26 Development of Innovative Therapeutics Conferenc 6304 1Joseph B Bolen Ph D from Millennium to Conference Chair Cancer Sessions at IBCs Drug Discovery 26 Development of Innovative Therapeutics Conferenc 6304 2ELADUR 28TM 29 Development Update 3A DURECT Receives Orphan Drug Designation for Bupivacaine for Post Herpetic Neuralgia 2550 1ELADUR 28TM 29 Development Update 3A DURECT Receives Orphan Drug Designation for Bupivacaine for Post Herpetic Neuralgia 2550 2ELADUR 28TM 29 Development Update 3A DURECT Receives Orphan Drug Designation for Bupivacaine for Post Herpetic Neuralgia 2550 3Zinc finger proteins put personalized HIV therapy within reach 22935 1Zinc finger proteins put personalized HIV therapy within reach 22935 2
...7 /PRNewswire/ -- Telomerase Activation,Sciences, ...s of,the Pivotal 2005 Anti-Aging Trial of TA-65, t...asurable and positive anti-aging,benefits from a T...ults were found in those taking TA-65 across sever...in immune system function, -- Improvement in v...
...tient trial show those treated with,Prexige experi...re,compared to ibuprofen[1] , * Many patients with...n small changes in blood pressure can impact,cardi... than 50 countries and currently under,review in U...zerland, June 15, 2007 - Patients with osteoarthri...
Other Medicine Technology:Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07,Teleconference to Answer Questions About TA-65, Their Telomerase,Activator With Proven Age Management Benefits 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 6
(Date:7/25/2008)...it ALS Therapy Alliance to be presented at Fenway ...SOCKET, R.I., July 25 /PRNewswire/ -- CVS/pharmacy...cord-breaking $4.4 million in just 21 days,through...research. This is,the seventh year of the annual f...than $15 million for ALS research. This year,s fun...
(Date:7/25/2008)...back-up in esophagus can cause immune system chang...-- The first evidence linking gastroesophageal ref...by Duke University Medical Center researchers. ,...rst noted in the 1970s, and since then studies hav...asthma patients also experience GERD symptoms. But...
(Date:7/25/2008)... New program delivers immediate cost saving...telephone access to language interpreters] to fir...ngual solutions. , Washin... http://www.lle-inc.com/index.html [(Language Lea...nterpretation, translation, and language instructi...
(Date:7/25/2008)... Whether you are an Olympian, Professional ...re Five Things You Need to Know about Hydration to... and Sports Center , Mari...a,s premier athletes are heading to Beijing follow...crifice in the hopes of capturing an Olympic medal...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:People With GERD More Likely to Develop Asthma 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...risk of death from prostate cancer, even though it...diagnosed with the disease.// Published in the i...rican Cancer Society, the study reveals that highe...in in adulthood correlated strongly with increased...
...ess’ is now being taught to Queensland women with ...echnique provides a// solution for women who strug...ght to help them understand and deal with the emot... many therapies for eating disorders, there is les...
...out the lack of natural B vitamin "folate" in the ... linked the inadequacy of this vitamin to birth de...o led to breads and cereals being supplemented wit...cially recommended to pregnant women. A nation-w...
...res end up in. Canada’s University of Calgary pr... of why we procrastinate, in a 30-page study publi... study took ten years instead of five, Steel has p...o decipher procrastination; Desire to Complete Tas...
Other Medicine News:Health News:Excess Weight and Adult Weight Gain Increase Risk of Prostate Cancer Death 2Health News:Read This Now Not Later! 2
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: